Publication:
Inhibition of Polyamine Oxidase Prevented Cyclin-Dependent Kinase Inhibitor-Induced Apoptosis in HCT 116 Colon Carcinoma Cells

dc.contributor.authorÇoker Gürkan, Ajda
dc.contributor.authorPalavan Ünsal, Narçin
dc.contributor.authorARISAN, ELİF DAMLA
dc.contributor.authorYERLİKAYA, PINAR OBAKAN
dc.contributor.authorID113920tr_TR
dc.contributor.authorID125860tr_TR
dc.contributor.authorID156421tr_TR
dc.contributor.authorID6125tr_TR
dc.date.accessioned2017-10-23T07:40:51Z
dc.date.available2017-10-23T07:40:51Z
dc.date.issued2013-12
dc.description.abstractRoscovitine and purvalanol are novel cyclin-dependent kinase (CDK) inhibitors that prevent cell proliferation and induce apoptotic cell death in various cancer cell lines. Although a number of studies have demonstrated the potential apoptotic role of roscovitine, there is limited data about the therapeutic efficiency of purvalanol on cancer cells. The natural polyamines (PAs) putrescine, spermidine, and spermine have essential roles in the regulation of cell differentiation, growth, and proliferation, and increased levels of these compounds have been associated with cancer progression. Recently, depletion of intracellular PA levels because of modulation of PA catabolic enzymes was shown to be an indicator of the efficacy of chemotherapeutic agents. In this study, our aim was to investigate the potential role of PA catabolic enzymes in CDK inhibitor-induced apoptosis in HCT 116 colon carcinoma cells. Exposure of cells to roscovitine or purvalanol decreased cell viability in a dose- and time-dependent manner. The selected concentrations of roscovitine and purvalanol inhibited cell viability by 50 % compared with control cells and induced apoptosis by activating the mitochondria-mediated pathway in a caspase-dependent manner. However, the apoptotic effect of purvalanol was stronger than that of roscovitine in HCT 116 cells. In addition, we found that CDK inhibitors decreased PA levels and significantly upregulated expression of key PA catabolic enzymes such as polyamine oxidase (PAO) and spermine oxidase (SMO). MDL-72,527, a specific inhibitor of PAO and SMO, decreased apoptotic potential of CDK inhibitors on HCT 116 cells. Moreover, transient silencing of PAO was also reduced prevented CDK inhibitor-induced apoptosis in HCT 116 cells. We conclude that the PA catabolic pathway, especially PAO, is a critical target for understanding the molecular mechanism of CDK inhibitor-induced apoptosis.tr_TR
dc.identifier.issn1360-8185
dc.identifier.pubmed23892915
dc.identifier.scopus2-s2.0-84889096256
dc.identifier.urihttp://hdl.handle.net/11413/1752
dc.identifier.wos326925900008
dc.language.isoen
dc.publisherSpringer, Van Godewijckstraat 30, 3311 Gz Dordrecht, Netherlands
dc.relationApoptosistr_TR
dc.subjectcolon cancertr_TR
dc.subjectapoptosistr_TR
dc.subjectCDK inhibitorstr_TR
dc.subjectpolyamine catabolism breast-cancer cellstr_TR
dc.subjectroscovitine-induced apoptosistr_TR
dc.subjectchemotherapeutic-agentstr_TR
dc.subjectprostate-cancertr_TR
dc.subjectleukemia-cellstr_TR
dc.subjectr-roscovitinetr_TR
dc.subjectin-vivotr_TR
dc.subjectmetabolismtr_TR
dc.subjectinductiontr_TR
dc.subjectkolon kanseritr_TR
dc.subjectapoptoztr_TR
dc.subjectCDK inhibitörleritr_TR
dc.subjectpoliamin katabolizmasıtr_TR
dc.subjectmeme kanseri hücreleritr_TR
dc.subjectroscovitine bağlı apoptoztr_TR
dc.subjectkemoterapötik-maddelertr_TR
dc.subjectprostat kanseritr_TR
dc.subjectlösemi hücreleritr_TR
dc.subjectmetabolizmatr_TR
dc.subjectindüksiyontr_TR
dc.titleInhibition of Polyamine Oxidase Prevented Cyclin-Dependent Kinase Inhibitor-Induced Apoptosis in HCT 116 Colon Carcinoma Cellstr_TR
dc.typeArticle
dspace.entity.typePublication
local.indexed.atWOS
local.indexed.atPubMed
local.indexed.atScopus
relation.isAuthorOfPublication3d33e154-a50c-46b8-ad6e-25a26bf11cf0
relation.isAuthorOfPublication387670e2-5a88-4937-b3da-1dda9aedfbdd
relation.isAuthorOfPublication.latestForDiscovery3d33e154-a50c-46b8-ad6e-25a26bf11cf0

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: